Braskem S.A. Reports Significant EBITDA Growth in 3Q25 Amid Industry Challenges

Braskem SA ( (BAK) ) has provided an announcement.

In the third quarter of 2025, Braskem S.A. reported a recurring EBITDA of US$150 million, marking a 104% increase from the previous quarter. The petrochemical industry faced challenges due to global supply-demand imbalances, affecting international market prices. In Brazil/South America, the company saw a 35% rise in recurring EBITDA to US$205 million, despite a 5% drop in resin sales. The United States and Europe segment experienced a negative recurring EBITDA of US$15 million, while in Mexico, operations were impacted by a major maintenance shutdown. The company’s corporate gross debt stood at approximately US$8.4 billion, with a cash position of US$1.3 billion.

The most recent analyst rating on (BAK) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Braskem SA stock, see the BAK Stock Forecast page.

Spark’s Take on BAK Stock

According to Spark, TipRanks’ AI Analyst, BAK is a Neutral.

Braskem SA’s overall stock score is primarily impacted by its weak financial performance, characterized by declining revenues, negative profitability, and high financial leverage. Technical analysis shows mixed signals with short-term momentum but potential overbought conditions. Valuation remains unattractive due to ongoing losses and the absence of a dividend yield.

To see Spark’s full report on BAK stock, click here.

More about Braskem SA

Braskem S.A. is the largest resin producer in the Americas and a global leader in biopolymers. The company operates in the petrochemical industry, focusing on the production of polyethylene (PE), polypropylene (PP), and polyvinyl chloride (PVC), with a significant market presence in Brazil, South America, the United States, Europe, and Mexico.

Average Trading Volume: 1,085,895

Technical Sentiment Signal: Sell

Current Market Cap: $1.05B

For an in-depth examination of BAK stock, go to TipRanks’ Overview page.